Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1996 4
2000 2
2001 1
2002 3
2003 4
2004 6
2005 6
2006 11
2007 8
2008 14
2009 7
2010 13
2011 10
2012 17
2013 12
2014 12
2015 26
2016 31
2017 22
2018 31
2019 30
2020 29
2021 2
Text availability
Article attribute
Article type
Publication date

Similar articles for PMID: 22144699

263 results
Results by year
Filters applied: . Clear all
Page 1
Corticosteroid pulse combination therapy for refractory Kawasaki disease: a randomized trial.
Ogata S, Ogihara Y, Honda T, Kon S, Akiyama K, Ishii M. Ogata S, et al. Pediatrics. 2012 Jan;129(1):e17-23. doi: 10.1542/peds.2011-0148. Epub 2011 Dec 5. Pediatrics. 2012. PMID: 22144699 Clinical Trial.
Effects of steroid pulse therapy on immunoglobulin-resistant Kawasaki disease.
Furukawa T, Kishiro M, Akimoto K, Nagata S, Shimizu T, Yamashiro Y. Furukawa T, et al. Arch Dis Child. 2008 Feb;93(2):142-6. doi: 10.1136/adc.2007.126144. Epub 2007 Oct 25. Arch Dis Child. 2008. PMID: 17962370
[Steroid pulse therapy].
Miura M. Miura M. Nihon Rinsho. 2014 Sep;72(9):1631-5. Nihon Rinsho. 2014. PMID: 25518414 Japanese.
[Methylprednisolone pulse therapy in Kawasaki disease].
Miura M, Matsuoka M, Kohno K, Ohki H, Yoshiba S. Miura M, et al. Nihon Rinsho. 2008 Feb;66(2):338-42. Nihon Rinsho. 2008. PMID: 18265457 Japanese.
Indirect-comparison meta-analysis of treatment options for patients with refractory Kawasaki disease.
Chan H, Chi H, You H, Wang M, Zhang G, Yang H, Li Q. Chan H, et al. BMC Pediatr. 2019 May 17;19(1):158. doi: 10.1186/s12887-019-1504-9. BMC Pediatr. 2019. PMID: 31101091 Free PMC article. Review.
Role of glucocorticoids in Kawasaki disease.
Miura M. Miura M. Int J Rheum Dis. 2018 Jan;21(1):70-75. doi: 10.1111/1756-185X.13209. Epub 2017 Nov 3. Int J Rheum Dis. 2018. PMID: 29105310 Review.
A multicenter prospective randomized trial of corticosteroids in primary therapy for Kawasaki disease: clinical course and coronary artery outcome.
Inoue Y, Okada Y, Shinohara M, Kobayashi T, Kobayashi T, Tomomasa T, Takeuchi K, Morikawa A. Inoue Y, et al. J Pediatr. 2006 Sep;149(3):336-341. doi: 10.1016/j.jpeds.2006.05.025. J Pediatr. 2006. PMID: 16939743 Clinical Trial.
Effects of methylprednisolone pulse on cytokine levels in Kawasaki disease patients unresponsive to intravenous immunoglobulin.
Miura M, Kohno K, Ohki H, Yoshiba S, Sugaya A, Satoh M. Miura M, et al. Eur J Pediatr. 2008 Oct;167(10):1119-23. doi: 10.1007/s00431-007-0642-5. Epub 2008 Jan 4. Eur J Pediatr. 2008. PMID: 18175148 Clinical Trial.
Intravenous immune globulin plus corticosteroids in refractory Kawasaki disease.
Jibiki T, Kato I, Shiohama T, Abe K, Anzai S, Takeda N, Yamaguchi KI, Kanazawa M, Kurosaki T. Jibiki T, et al. Pediatr Int. 2011 Oct;53(5):729-735. doi: 10.1111/j.1442-200X.2011.03338.x. Pediatr Int. 2011. PMID: 21342358
Clinical outcomes of initial dexamethasone treatment combined with a single high dose of intravenous immunoglobulin for primary treatment of Kawasaki disease.
Lim YJ, Jung JW. Lim YJ, et al. Yonsei Med J. 2014 Sep;55(5):1260-6. doi: 10.3349/ymj.2014.55.5.1260. Yonsei Med J. 2014. PMID: 25048483 Free PMC article.
263 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback